Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Ranibizumab in Choroidal Melanoma
NCT01251978Phase 2Completed
- Start
- Jul 2010
- Primary completion
- Jul 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in choroidal melanoma. Started Jul 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
choroidal melanoma
Beyond the preview
Go deeper on NCT01251978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251978.